Kronos bio to present data at the eortc-nci-aacr symposium that supports p300 kat inhibition in hpv-driven tumors

– data show that p300 kat inhibitor kb-9558 was highly selective against human papillomavirus (hpv) oncoproteins e6 and e7, and therefore drove anti-tumor effects –

NCI Ratings Summary

NCI Quant Ranking